• SENSEX 80,710.25
    -308.47 (--0.38%)
  • BANKNIFTY 55,360.25
    -259.10 (--0.47%)
  • One 97
    1,050.95 481.75(%)
  • HDFC Bank
    1,967.00 1,593.20(%)
  • ICICI Bank
    1,440.95 1,153.30(%)
  • Aditya Infotech
    1,104.20 1,104.20(%)
  • Newgen Software
    968.75 1,795.50(%)
  • Godfrey Phillips
    9,891.25 9,891.25(%)
  • Reliance Industr
    1,388.10 1,115.55(%)
  • Jayaswal Neco
    55.85 55.85(%)
  • Tanla Platforms
    685.95 990.00(%)
  • Tata Inv.Corpn.
    7,625.00 8,075.90(%)
  • Infosys
    1,454.75 1,307.10(%)
  • KIOCL
    410.00 453.05(%)
  • APL Apollo Tubes
    1,633.60 1,935.00(%)
  • IndusInd Bank
    848.80 1,498.70(%)
  • Tata Motors
    659.00 1,142.00(%)
  • Chambal Fert.
    570.00 742.45(%)
  • Medplus Health
    865.95 603.00(%)
  • New India Assura
    205.00 278.00(%)
  • M & M
    3,221.15 3,302.90(%)
  • SBI
    803.65 875.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shilpa Medicare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5031.0
  • ISIN : INE790G01031
861.90 12 (1.35%)
  • As on 06 Aug 2025 (EOD)

  • Today’s Low

    832.25

  • Today’s High

    872.00

  • Open

    850.40

  • Perv Close

    850.40

  • 52W Low

    555.00

  • 52W High

    1,000.00

Key Indicators

  • P/E(TTM)

    88.49

  • Mar.Cap (₹Cr.)

    8,428.60

  • Div & Yield %

    0.12

  • Book Value(₹)

    276.16

  • Debt-Equity Ratio

    1.35

  • AGM Date

    05-Aug-2025

  • EPS

    9.76

  • P/E Ratio

    88.49

Financials Ratios

  • Debt-Equity Ratio

    0.48

  • Mar.Cap (₹Cr.)

    8,428.60

  • RONW (%)

    1.72

  • ROCE (%)

    5.16

Score Board

  • Equity (₹ in Cr.)

    9.78

  • BV (₹)

    276.20

  • Sales( ₹ in Cr.)

    477.34

  • NP (in Cr.)

    95.46

  • NP Var(%)

    182.0

  • Div%

    100.0

  • CPS (₹)

    14.80

  • EPS (₹)

    9.80

  • Traded Value (₹ in Lakhs)

    8,445.71

  • 52 Week High

    1,000.00

  • 52 Week Low

    555.00

  • Price BSE

    864.0

  • Price NSE

    862.00

  • Market Capital( in Cr.)

    8,445.71

  • P/C Ratio

    58.50

  • P/E Ratio

    88.50

  • Price Vs.BV

    9.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 309.79 247.70 356.95 257.05 805.97 663.88
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 309.79 247.70 356.95 257.05 805.97 663.88
Other Income 89.12 175.32 170.50 204.49 36.79 41.73
Stock Adjustments -2.63 -4.08 3.18 10.26 14.26 9.92
Total Income 396.28 418.94 530.63 471.80 857.02 715.53
EXPENDITURE :            
Raw Materials 86.62 78.12 81.96 69.37 279.83 244.80
Power and Fuel Cost 18.73 18.70 17.47 12.42 35.31 31.39
Employee Cost 103.64 109.54 110.57 76.10 149.28 124.66
Other Manufacturing Expenses 15.32 18.28 22.79 16.71 35.94 34.12
Selling and Administration Expenses 49.74 60.03 106.22 55.92 67.02 39.32
Miscellaneous Expenses 17.26 18.50 -0.57 3.43 12.50 42.60
Employee Benefit Expenses 103.64 109.54 110.57 76.10 149.28 124.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 291.31 303.17 338.44 233.95 579.87 516.87
Operating Profit 104.96 115.78 192.18 237.86 277.15 198.66
Interest 17.26 20.83 9.05 6.07 4.33 2.79
Gross Profit 87.70 94.95 183.13 231.79 272.82 195.87
Depreciation 49.61 46.55 34.82 22.28 34.96 34.01
Profit Before Tax 38.09 48.40 148.31 209.51 237.86 161.86
Current Tax 11.29 -8.37 4.80 15.78 39.09 40.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.13 -0.43 2.53 9.34 5.05 -2.76
Reported Net Profit 26.94 57.19 140.99 184.39 193.72 124.11
Extraordinary Items -6.93 -15.86 8.23 46.40 -3.65 6.89
Adjusted Net Profit 33.87 73.05 132.76 137.99 197.37 117.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,332.11 1,284.46 1,152.44 968.05 794.97 670.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 9.55 8.97 0.00 20.64 0.00
P & L Balance carried down 1,359.05 1,332.11 1,284.46 1,152.44 968.05 794.97
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 110.00 110.00 110.00 100.00
Dividend Per Share(Rs) 0.00 0.00 1.10 1.10 1.10 1.00
Earnings Per Share-Unit Curr 3.10 6.59 16.24 22.62 23.76 15.22
Earnings Per Share(Adj)-Unit Curr 3.10 6.59 16.24 22.62 23.76 15.22
Book Value 246.85 243.96 237.97 200.89 178.27 157.19
Book Value(Adj)-Unit Curr 246.85 243.96 237.97 200.89 178.27 157.19

Shareholding Pattern

  • Promoter Group

    44.23%

  • Public Share Holding

    55.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 43,249,715 44.23 43,249,715 23
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 43,249,715 44.23 43,249,715 23
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 502 0.00 502 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 1,500 0.00 1,500 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,946,921 11.19 10,946,921 97
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,926,798 1.97 1,926,798 2
Mutual Funds / UTI 3,963,485 4.05 3,963,485 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,407,508 1.44 1,407,508 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,246,714 18.66 18,246,714 120
2] Non Institution
Bodies Corporate 10,046,438 10.27 10,046,438 745
Clearing Members 7,565 0.01 7,565 5
Directors of their Relatives 31,075 0.03 31,075 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,468,741 2.52 2,468,741 1,099
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 755,239 0.77 755,239 1,178
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,654,783 6.81 6,654,783 12
Individuals holding nominal share capital up to Rs. 1 lakh 16,042,258 16.40 15,917,494 45,446
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,033 0.00 2,033 4
Others 286,347 0.29 286,347 2
Sub Total 36,294,479 37.11 36,169,715 48,493
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 97,790,908 100.00 97,666,144 48,636

Company Background

Shilpa Medicare LtdPharmaceuticals - Indian - Formulations

  • Shilpa Medicare Ltd
  • BSE Code : 5031.0
  • ISIN : INE790G01031

  • Incorporation Year

    1987

  • Registered Office

    #12-6-214/A1
    Hyderabad Road, Raichur,
    Karnataka-584135

  • Telephone

    91-8532-238704

  • FAX

    91-8532238876

  • Chairman

    Omprakash Inani

  • Managing Director

    Vishnukant Bhutada

  • Company Secretary

    Ritu Tiwary

  • Auditor

    Bohara Bhandari Bung And Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Shilpa Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shilpa Medicare 863.65 398.90 309.79 120.96 2.77
Abbott India 33,260.70 6,684.73 6,409.15 49.97 44.95
Astrazeneca Phar 8,853.35 1,756.92 1,716.29 191.22 32.94
P & G Health Ltd 6,185.55 1,166.89 1,151.26 34.16 39.76
Glaxosmi. Pharma 2,840.30 3,866.05 3,723.49 51.08 58.72
Cipla 1,499.25 20,029.57 19,044.85 22.41 21.40
Amrutanjan Healt 688.35 437.58 421.23 39.16 20.84
Fermenta Biotec. 360.00 442.21 430.53 15.67 17.61
Guj. Themis Bio. 358.25 174.19 169.82 87.59 44.82
Bliss GVS Pharma 179.40 703.42 667.20 26.82 9.16
Ambalal Sarabhai 32.11 19.33 4.04 29.73 2.10